Healthcare Sector Review: Winning and Losing Stocks on Nov 4th

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • Inhibitex, Inc. (NASDAQ:INHX): The shares closed at $8.54, up $4.58, or 115.66%, on the day. Its market capitalization is $667.70 million. About the company: Inhibitex Inc. is a biopharmaceutical company that discovers, develops, and commercializes novel antibody-based products. The Company develops products for the prevention and treatment of serious bacterial and fungal infections in the hospital setting. Get the most recent company news and stock data here >>
  • AMAG Pharmaceuticals, Inc (NASDAQ:AMAG): The shares closed at $16.20, up $2.45, or 17.82%, on the day. Its market capitalization is $343.49 million. About the company: AMAG Pharmaceuticals, Inc., a biopharmaceutical company, utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. Get the most recent company news and stock data here >>
  • Insulet Corporation (NASDAQ:PODD): The shares closed at $17.00, up $2.15, or 14.48%, on the day. Its market capitalization is $803.92 million. About the company: Insulet Corporation is a medical device company that develops, manufactures and markets an insulin infusion system for people with insulin-dependent diabetes. Get the most recent company news and stock data here >>
  • Acorda Therapeutics Inc. (NASDAQ:ACOR): The shares closed at $23.08, up $2.63, or 12.86%, on the day. Its market capitalization is $915.30 million. About the company: Acorda Therapeutics Inc. is a biotechnology company that is developing therapies for spinal cord injury and related neurological conditions, including multiple sclerosis. Additionally, Acorda is developing multiple approaches to regeneration and repair of the spinal cord and brain. Get the most recent company news and stock data here >>
  • NuVasive, Inc. (NASDAQ:NUVA): The shares closed at $15.19, up $1.15, or 8.19%, on the day. Its market capitalization is $605.78 million. About the company: NuVasive, Inc. designs, develops, and markets products for the surgical treatment of spine disorders. The Company’s products include Maximum Access Surgery (NYSE:MAS) and Fusion products. Get the most recent company news and stock data here >>

Losers (% price change)

  • Seattle Genetics, Inc. (NASDAQ:SGEN): The shares closed at $18.01, down $3.95, or 17.99%, on the day. Its market capitalization is $2.07 billion. About the company: Seattle Genetics, Inc. discovers and develops monoclonal antibody-based drugs to treat cancer and related diseases. The Company’s technologies increase the potency and efficacy of monoclonal antibodies with specificity for cancer. Get the most recent company news and stock data here >>
  • Optimer Pharmaceuticals (NASDAQ:OPTR): The shares closed at $12.38, down $2.26, or 15.44%, on the day. Its market capitalization is $576.95 million. About the company: Optimer Pharmaceuticals, Inc. discovers, develops, and commercializes anti infective products. Optimer’s initial development efforts address products that treat gastrointestinal infections (GI), and related diseases, including diminished efficacy, serious adverse side effects, drug-to-drug interactions, difficult patient compliance, and bacterial resistance. Get the most recent company news and stock data here >>
  • Amarin Corp. plc (NASDAQ:AMRN): The shares closed at $7.32, down $1.17, or 13.78%, on the day. Its market capitalization is $974.80 million. About the company: Amarin Corporation PLC is a clinical-stage biopharmaceutical company. The Company researches, develops, and commercializes drugs for the treatment of hypertriglyceridemia, central nervous system disorders, and cardiovascular diseases. Get the most recent company news and stock data here >>
  • MELA Sciences, Inc. (NASDAQ:MELA): The shares closed at $4.66, down $0.71, or 13.22%, on the day. Its market capitalization is $117.72 million. About the company: MELA Sciences Inc is a medical device company focused on the design and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma. The Company’s product features a device that captures images of suspicious pigmented skin lesions and extracts data. Get the most recent company news and stock data here >>
  • Cadence Pharmaceuticals (NASDAQ:CADX): The shares closed at $5.00, down $0.73, or 12.74%, on the day. Its market capitalization is $318.07 million. About the company: Cadence Pharmaceuticals Inc. is a biopharmaceutical company that develops drugs for use in hospitals. The Company produces intravenous APAP for the treatment of acute pain and fever, and omiganan for the prevention of intravascular catheter-related infections. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet